The Act on Protection against Measles and Strengthening Vaccine Prevention (Measles Protection Act) has been in force since 1 March 2020. This law is intended to provide better protection against measles, particularly for children. Information for parents and guardians, employees of community facilities and medical institutions, institution managers, and healthcare professionals is published at www.masernschutz.de. The German Federal Ministry of Health, the Federal Centre for Health Education, the Robert Koch-Institut, and the Paul-Ehrlich-Institut jointly developed the content.

Updated: 06.09.2024

Information on ingredients, excipients and additives, use, interactions, contraindications, and side effects can be found in the medicinal products' package leaflet and product information.

The Paul-Ehrlich-Institut, the Federal Institute for Vaccines and Biomedicines, offers lists of vaccines authorised in Germany on its website. "Further information" links are provided in the far right-hand column of the lists. In the case of centrally authorised products, these links lead to the EPAR (European Public Assessment Report), which contains details such as the product information. For all other authorisations (national, decentralised, mutual recognition procedure), the links connect to the PharmNet.Bund database (German only). After accepting the disclaimer and clicking on the name of the medicinal product, the product information or package leaflet can be downloaded by clicking on the "additional documents" (Zusatzdokumente) tab.

Updated: 06.09.2024